中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 6
Jun.  2018
Turn off MathJax
Article Contents

Antioxidant effect of berberine in a rat model of nonalcoholic steatohepatitis

DOI: 10.3969/j.issn.1001-5256.2018.06.028
  • Received Date: 2018-02-05
  • Published Date: 2018-06-20
  • Objective To investigate the antioxidant effect of berberine in a rat model of nonalcoholic steatohepatitis (NASH) and an in vitro model of oxidative stress induced by H2 O2. Methods High-fat diet was used to establish a rat model of NASH. After three weeks of treatment with berberine 18 mg/kg/d by gavage, HE staining was used to observe liver pathological changes, and the activities of glutathione (GSH) and superoxide dismutase (SOD) and the level of malondialdehyde (MDA) in liver tissue were measured. An in vitro model of oxidative stress induced by reactive oxygen species (ROS) due to H2 O2 was established; flow cytometry was used to measure the level of ROS, and the activities of SOD, GSH, lactate dehydrogenase (LDH) , and chloramphenicol acetyltransferase (CAT) in hepatocytes were measured. A one-way analysis of variance was used for comparison of continuous data between groups, and the Bonferroni test was used for further comparison between two groups; the t-test was used for comparison of continuous data between two groups. Results NASH rats had significant improvements in the extent of infiltration of inflammatory cells, focal necrosis, and ballooning degeneration of hepatocytes after berberine treatment. Compared with the NASH model group, the berberine group had significant increases in the activities of GSH (29. 8 ±2. 4 U/mg vs 19. 9 ± 1. 3 U/mg, P < 0. 001) and SOD (26. 6 ± 1. 9 μg/mg vs 19. 7 ± 1. 4 μg/mg, P < 0. 001) and a significant reduction in the level of MDA (19. 8 ± 1. 5 nmol/mg vs 24. 0 ± 2. 0 nmol/mg, P < 0. 001) . In the in vitro model of oxidative stress induced by H2 O2, the H2 O2 group had a significant increase in the level of ROS compared with the berberine + H2 O2 group (69. 8% ± 1. 9% vs 50. 4% ±6. 5%, t = 24. 42, P = 0. 008) . Compared with the H2 O2 group, the berberine + H2 O2 group had significant increases in the activities of SOD (25. 5 ± 1. 3 μg/mg vs 18. 8 ± 1. 0 μg/mg, P < 0. 001) and GSH (27. 1 ± 0. 6 U/mg vs 16. 79 ± 3. 8 U/mg, P < 0. 001) in hepatocytes; there was no significant difference in the level of LDH between the berberine + H2 O2 group and the H2 O2 group (P = 0. 103) , and there was no significant difference in the activity of CAT across all groups (F = 3. 76, P = 0. 060) . Conclusion Both in vivo and in vitro models show that berberine has a good antioxidant effect, possibly by increasing the activities of antioxidant enzymes.

     

  • loading
  • [1]POPRAC P, JOMOVA K, SIMUNKOVA M, et al.Targeting free radicals in oxidative stress-related human diseases[J].Trends Pharmacol Sci, 2017, 38 (7) :592-607.
    [2]ANDRISIC L, DUDZIK D, BARBAS C, et al.Short overview on metabolomics approach to study pathophysiology of oxidative stress in cancer[J].Redox Biol, 2018, 14:47-58.
    [3]LI S, HONG M, TAN HY, et al.Insights into the role and interdependence of oxidative stress and inflammation in liver diseases[J].Oxid Med Cell Longev, 2016, 2016:4234061.
    [4]AI ZL, XIE BS, YAO SK.Clinical effect of matrine in treatment of rats with nonalcoholic steatohepatitis[J].J Clin Hepatol, 2016, 32 (11) :2163-2166. (in Chinese) 艾正琳, 谢步善, 姚树坤.苦参碱治疗非酒精性脂肪性肝炎大鼠的效果观察[J].临床肝胆病杂志, 2016, 32 (11) :2163-2166.
    [5]SAHEBKAR A, WATTS GF.Mode of action of berberine on lipid metabolism:A new-old phytochemical with clinical applications?[J].Curr Opin Lipidol, 2017, 28 (3) :282-283.
    [6]SUN YP.Effect of Berberine on the serum levels of IL-10, IL-6and CRP in patients with type 2 diabetes mell[J].J Changchun Univ Chin Med, 2017, 33 (3) :431-433. (in Chinese) 孙永平.黄连素对2型糖尿病患者血清IL-10、IL-6及CRP水平的影响[J].长春中医药大学学报, 2017, 33 (3) :431-433.
    [7]The Chinese National Workshop on Fatty Liver and Alcoholic Liver Disease for the Chinese Liver Disease Association.Guidelines for management of nonalcoholic fatty liver disease:an updated and revised edition[J].J Clin Hepatol, 2010, 26 (2) :120-124. (in Chinese) 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南 (2010年修订版) [J].临床肝胆病杂志, 2010, 26 (2) :120-124.
    [8]LISBOA QC, COSTA SM, COUTO CA.Current management of non-alcoholic fatty liver disease[J].Rev Assoc Med Bras, 2016, 62 (9) :872-878.
    [9]CALABRESE G, MORGAN B, RIEMER J.Mitochondrial glutathione:regulation and functions[J].Antioxid Redox Signal, 2017, 27 (15) :1162-1177.
    [10]CHANDIRASEGARAN G, ELANCHEZHIYAN C, GHOSH K.Effects of Berberine chloride on the liver of streptozotocin-induced diabetes in albino Wistar rats[J].Biomed Pharmacother, 2018, 99 (12) :227-236.
    [11]PAECH F, MINGARD C, GRUNIG D, et al.Mechanisms of mitochondrial toxicity of the kinase inhibitors ponatinib, regorafenib and sorafenib in human hepatic Hep G2 cells[J].Toxicology, 2018, 395:34-44.
    [12]SIMES ICM, FONTES A, PINTON P, et al.Mitochondria in non-alcoholic fatty liver disease[J].Int J Biochem Cell Biol, 2017, 95:93-99.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (1632) PDF downloads(352) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return